1 Min Read
Jan 5 (Reuters) - NanoCarrier Co Ltd :
* Says it commenced phase I/II clinical trial for treatment of soft tissue sarcomas in the United States
Source text in Japanese:goo.gl/huQUEn
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.